Synthesis and Preclinical Evaluation of <sup>177</sup> Lu-CHX-A”-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma - Concepedia

Concepedia

Publication | Closed Access

Synthesis and Preclinical Evaluation of <sup>177</sup> Lu-CHX-A”-DTPA-Rituximab as a Radioimmunotherapeutic Agent for Non-Hodgkin's Lymphoma

22

Citations

29

References

2015

Year

Mythili Kameswaran, Usha Pandey, Chetan Dhakan, Kamal Pathak, Vikram Gota, K.V. Vimalnath, Ashutosh Dash, Grace Samuel

Cancer Biotherapy and Radiopharmaceuticals

Abstract

In vitro and in vivo studies showed good specificity of (177)Lu-CHX-A"-DTPA-Rituximab toward CD20 antigen. It can be concluded that (177)Lu-CHX-A"-DTPA-Rituximab could be a promising agent in the treatment of NHL.

References

	Year	Citations

Page 1